BioIntellisense Stock
HealthTechLooking to sell BioIntellisense stock or options?
BioIntellisense has developed a remote patient monitoring device aimed at revolutionizing healthcare delivery. This device ensures continuous and passive tracking of vital signs and biometrics using medical-grade wearables, offering actionable health insights that support early intervention. By doing so, BioIntellisense enables healthcare providers to enhance patient outcomes, streamline clinical workflows, and minimize hospital readmissions.
Chimera Capital, Dexcom Ventures, Mary Tolan, University of Colorado Health, Pendrell, Philips, Confluent, iD Ventures America, TT Capital Partners, Fresenius Medical Care, Royal Philips Electronics (Restoratives and Impression Portfolios), CU Healthcare Innovation Fund, Philips Ventures, Fresenius Medical Care Ventures, Skypoint Ventures, United States Army, James Murren, TLG Capital Management, Jonathan Weiner.